Abstract
We describe the molecular mechanisms of apoptosis and its relationships with hematologic malignancies, stressing the concept that, both positive and negative deregulation of apoptosis, may be involved in hematologic human diseases. So, this fundamental process must be balanced by so far unknown mechanisms, involving caspases (cysteine proteases, cleaving the protein substrate after an aspartate residue). These, so far known, ten proteases, are interconnected in a molecular cascade, initiated by the release of cytochrome C from mitochondrial membranes and its interaction with APAF-1 (the homolog of the Caenorhabditis e. CED-4) and with caspase 9, that initiates the proteolitic cascade (1,2). The conclusion is that apoptosis is a very important process, but yet poorly known in molecular details, in spite of the efforts of many scientists. Even the role of bcl-2, the main gene protecting from apoptosis, is still unknown. We close this chapter with a list of ten different technical approaches that can be useful tools to study apoptosis, and tracing the molecular principles on which they are based.
Similar content being viewed by others
References
Ceccibum F,m Akvarez-Balado, G., Meyer, B. I., Roth, K. A., and Gruss, P. (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94, 727–737.
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemre, E. S., and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (4), 479–489.
Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E., Longthorne, V., Culhane, A. C., and Williams, G. T. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236, 1–26.
Vaux, D. L. and Strasser, A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239–2244.
Vaux, D. L., Weissman, I. L., and Kim, S. K. (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258, 1955–1957.
Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991) Mechanisms of functions of cell death. Ann. Rev. Cell. Biol. 7, 663–698.
Yuan, J., Shahan, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641–652.
Miura, M., Zhu, H., Rotello, R., Hartwiegh, E. A., and Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653–660.
Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269, 30,761–30,764.
Munday, N. A., Villancourt, J. P., Ali, A., et al. (1995) Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270, 15,870–15,876.
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346–347.
Itoh, N., and Nagata, S. (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10,932–10,937.
Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O’Rourke, K., Kischkel, F. C., et al. (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961–4965.
Chinnaiyan, A. M., O’Rourke, K., Yu, G. L., et al. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990–992.
Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355–365.
Fisher, G. H., Rosenberg, F. J, Straus, S. E., et al. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946.
Tanaka, M., Suda, T., Haze, K., et al. (1996) Fas ligand in human serum. Nat. Med. 2, 317–322.
Bottino, C., Tambussi, G., Ferrini, S., et al. (1988) Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J. Exp. Med. 168, 491–505.
Cohen, J. J. (1993) Apoptosis. Immunol. Today 14, 126–130.
Curnow, S. J., Glennie, M. J., and Stevenson, G. T. (1993) The role of apoptosis in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 36, 149–155.
Cleary, M. L., Smith, S. D., and Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19–28.
Magrath, I. (1990) The pathogenesis of Burkitt’s lymphoma. Adv. Cancer Res. 55, 133–270.
Okan, I., Wang, Y., Chen, F., et al. (1995) The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11, 1027–1031.
Silins, S. L. and Sculley, T. B. (1995) Burkitt’s lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 60, 65–72.
Yonish-Rouach, E., Grunwald, D., et al. (1993) p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13, 1415–1423.
Matulonis, U., Salgia, R., Okuda, K., Druher, B., and Griffin, J. D. (1993) Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent cell line. Exp. Hematal. 21, 1460–1466.
Cheng, J., Zhou, T., Liu, C., et al. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759–1762.
Strasser. A., Harris, A. W., and Cory, S. (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889–899.
Rajapaksa, R., Ginzton, N., Rott, L. S., and Greenberg, P. L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88, 4275–4287.
Yoshida, Y. (1993) Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 7, 144–146.
Cotter, T. G., Glynn, J. M., Echeverri, F., and Green, D. R. (1992) The induction of apoptosis by chemoterapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12, 773–779.
Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462.
Groux, H., Torpier, G., Monte, D., Mouton, Y., Capron, A., and Amisen, J. C. (1992) Activation-induced death by apoptosis in CD4+ T cells from human immuno-deficiency virus-infected asymptomatic individuals. J. Exp. Med. 175, 331–340.
Magnelli, L., Cinelli, M., and Chiarugi, V. (1995) Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-p53/K562 from apoptosis. Biochem. Biophys. Res. Commun. 215, 641–645.
Magnelli, L., Cinelli, M., and Chiarugi, V. (1993) Apoptosis induction in 32D cells by IL-3 withdrawal is preceded by a drop in the intracellular calcium level. Biochem. Biophys. Res. Commun. 194, 1394–1397.
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501.
Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., and Traganos, F. (1997) Cytometry in cell necrobiology: analisis of apoptosis and accidental cell death necrosis. Cytometry 27, 1–20.
Frankfurt, O. S. (1999) Immunoassay for single-stranded DNA in apoptotic cells. Methods Mol. Biol. 113, 621–631.
Homburg, C. H., de Haas, M., von der Borne, A. E., Verhoeven, A. J., Reutelingsperger, C. P., and Roos, D. (1995) Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85, 532–540.
D’Mello, S. R., Aglieco, F., Roberts, M. R., Borodezt, K., and Haycock, J. W. (1998) A DEVD-inhibited caspase other than CPP32 is involved in the committment of cerebellar granule neurons to apoptosis induced by K+ deprivation. J. Neurochem. 70, 1809–1818.
Kumar, S. and Colussi, P. A. (1999) Prodomains—adaptors—oligomerization: the pursuit of caspase activation in apoptosis. Trends Biochem. Sci. 24, 1–4.
Thornberry, N. and Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312–1316.
Smith, M. J., and Trapani, J. A. (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 16, 202–206.
Hahne, M., Peitsch, M. C., Irmler, M., et al. (1995) Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7, 1381–1386.
Hahne, M., Rimoldi, D., Scrhoter, M., et al. (1996) Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363–1366.
Thilenius, A. R., Braun, K., and Russell, J. H. (1997) Agonist antibody and Fas ligand mediate different sensitivity to death in the signalling pathway of Fas and cytoplasmic mutants. Eur. J. Immunol. 27, 1108–1114.
Hannun, Y. A. and Obeid, L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73–77.
Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855–1959.
Pepper, J. S., Montesano, R., Mandriota, S. J., Orci, L., and Vassalli, J. D. (1996) Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138–162.
Rosen, A., Casciold-Rosen, L. (1997) Macromolecular substrates for the ICE-like proteases during apoptosis. J. Biol. Chem. 64, 50–54.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiarugi, V., Cinelli, M., Magnelli, L. et al. Apoptosis: Molecular regulation of cell death and hematologic malignancies. Mol Biotechnol 20, 305–314 (2002). https://doi.org/10.1385/MB:20:3:305
Issue date:
DOI: https://doi.org/10.1385/MB:20:3:305